Analysis Of Differences In Hta Reimbursement Decisions Of Stage Iv (Metastatic) Breast Cancer Medications Across Different Countries
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.1358
https://www.valueinhealthjournal.com/article/S1098-3015(15)03434-8/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
852
First Page :
A490
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03434-8&doi=10.1016/j.jval.2015.09.1358